BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around ...

A US-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

To keep your teams high-performing and achieve better business results, leaders need to understand the hidden costs of DX and ...

StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the medical research company’s ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Dynex Capital, Inc. (NYSE:DX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five analysts that ...

Amanda Schneider's talk, "Work is broken. Gen Z can help fix it," is about Gen Z's influence in shaping the future of work.

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

HyperDX is an open-source observability platform built on ClickHouse that provides a seamless OpenTelemetry-native experience ...